tradmap

MOH Earnings Molina Healthcare, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$9 $6 $20 $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $23B $45B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$512M $334M $1B $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$3 $1 $6 $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $6B $11B Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
-$160M $83M $326M $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–60 of 60
Q3 20262026-09-300.732026-10-2210-Q
Q2 20262026-06-301.192026-07-2310-Q
Q1 20262026-03-310.272026-04-2310-Q
Q4 2025 (derived)2025-12-31-2.792026-02-1010-K
FY 20252025-12-318.922026-02-1010-K
Q3 20252025-09-301.512025-10-2310-Q
Q2 20252025-06-304.752025-07-2410-Q
Q1 20252025-03-315.452025-04-2410-Q
Q4 2024 (derived)2024-12-314.432025-02-1110-K
FY 20242024-12-3120.422025-02-1110-K
Q3 20242024-09-305.652024-10-2410-Q
Q2 20242024-06-305.172024-07-2510-Q
Q1 20242024-03-315.172024-04-2510-Q
Q4 2023 (derived)2023-12-313.692024-02-1310-K
FY 20232023-12-3118.772024-02-1310-K
Q3 20232023-09-304.212023-10-2610-Q
Q2 20232023-06-305.352023-07-2710-Q
Q1 20232023-03-315.522023-04-2710-Q
Q4 2022 (derived)2022-12-310.962023-02-1310-K
FY 20222022-12-3113.552023-02-1310-K
Q3 20222022-09-303.952022-10-2710-Q
Q2 20222022-06-304.252022-07-2810-Q
Q1 20222022-03-314.392022-04-2810-Q
Q4 2021 (derived)2021-12-311.742022-02-1410-K
FY 20212021-12-3111.252022-02-1410-K
Q3 20212021-09-302.462021-10-2810-Q
Q2 20212021-06-303.162021-07-2910-Q
Q1 20212021-03-313.892021-04-2910-Q
Q4 2020 (derived)2020-12-310.562021-02-1610-K
FY 20202020-12-3111.232021-02-1610-K
Q3 20202020-09-303.102020-10-2910-Q
Q2 20202020-06-304.652020-07-3110-Q
Q1 20202020-03-312.922020-05-0110-Q
Q4 20192019-12-312.672020-02-1410-K
FY 20192019-12-3111.472020-02-1410-K
Q3 20192019-09-302.752019-10-3010-Q
Q2 20192019-06-303.062019-07-3110-Q
Q1 20192019-03-312.992019-04-3010-Q
Q4 20182018-12-313.012019-02-1910-K
FY 20182018-12-3110.612019-02-1910-K
Q3 20182018-09-302.902018-11-0110-Q
Q2 20182018-06-303.022018-08-0110-Q
Q1 20182018-03-311.642018-04-3010-Q
Q4 20172017-12-31-4.592018-03-0110-K
FY 20172017-12-31-9.072018-03-0110-K
Q3 20172017-09-30-1.702017-11-0710-Q
Q2 20172017-06-30-4.102017-08-0210-Q
Q1 20172017-03-311.372017-05-0410-Q
Q4 20162016-12-31-0.852017-03-0110-K
FY 20162016-12-310.922017-03-0110-K
Q3 20162016-09-300.762016-10-2710-Q
Q2 20162016-06-300.582016-07-2710-Q
Q1 20162016-03-310.432016-05-0310-Q
Q4 20152015-12-310.522016-02-2610-K
FY 20152015-12-312.582016-02-2610-K
Q3 20152015-09-300.772015-10-2910-Q
Q2 20152015-06-300.722015-07-3010-Q
Q1 20152015-03-310.562015-05-0710-Q
Q4 20142014-12-310.692015-02-2610-K
FY 20142014-12-311.292015-02-2610-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.